Vincent Perrone | Director-Corporate Communication |
Steven Shallcross | Acting Chief Executive Officer and Chief Financial Officer |
Joseph Sliman | Chief Medical Officer |
Keith Markey | Griffin Securities |
Tim Chiang | BTIG |
Good afternoon, and welcome to the Synthetic Biologics 2018 First Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communication at Synthetic Biologics. Please go ahead.